Delaying the second dose of COVID-19 vaccines, at least for people aged under 65, could result in up to 20% lower mortality, but only under certain […]
A large trial of annual screening tests for ovarian cancer showed they did not reduce deaths despite picking up cancers earlier,1 ruling out the possibility of […]
AbstractObjectiveTo estimate population health outcomes with delayed second dose versus standard schedule of SARS-CoV-2 mRNA vaccination.DesignSimulation agent based modeling study.SettingSimulated…